Formulation A + Formulation B6 for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Feb 2026: Trial registered, NCT07407348
  2. 11 Mar 2026: Trial started, NCT07407348

The trials

NCT07407348: A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

State
Under way
Phase
Phase 1
People
80 taking part
Started
11 Mar 2026
Primary completion
9 Apr 2027
Arms
Formulation A, then Formulation B6, Formulation B6, then Formulation A
Results
None posted
  1. 12 Feb 2026: Trial registered
  2. 11 Mar 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.